ALZ-101

N/A

Report date: 2024/12/02 11:49:12

Base Information

Drug NameALZ-101
Drug Alias NameALZ-101
ClassificationVaccines
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer DiseaseDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFinland
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlzinova AB
China Registration ClassN/A

Develop Information

Active CompaniesAlzinova AB
Inactive CompaniesN/A
Active IndicationsAlzheimer DiseaseDementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A